Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
IDRA
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct | 6,166 Added 15.11% |
$13,874
$2.25 p/Share
|
Oct 01
2020 |
IDRA
|
Howard H Pien
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,583 Added 10.94% |
$12,562
$2.25 p/Share
|
Oct 01
2020 |
IDRA
|
Carol Schafer |
BUY
Grant, award, or other acquisition
|
Direct | 6,111 Added 11.99% |
$13,750
$2.25 p/Share
|
Oct 01
2020 |
TPHS
|
Joanne Minieri
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,351 Added 4.44% |
-
|
Oct 01
2020 |
TPHS
|
Jeffrey B Citrin |
BUY
Grant, award, or other acquisition
|
Direct | 16,843 Added 10.28% |
-
|
Oct 01
2020 |
TPHS
|
Alexander C Matina
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,884 Added 11.77% |
-
|
Oct 01
2020 |
TPHS
|
Keith M Pattiz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 16,932 Added 15.64% |
-
|
Oct 01
2020 |
TPHS
|
Alan Cohen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,938 Added 11.52% |
-
|
Oct 01
2020 |
SANW
|
David Thomas Callachor
Executive VP, International |
BUY
Grant, award, or other acquisition
|
Direct | 13,817 Added 27.66% |
-
|
Oct 01
2020 |
SANW
|
Donald M. Panter Jr.
Executive VP, Americas |
SELL
Payment of exercise price or tax liability
|
Direct | 600 Reduced 1.56% |
$1,446
$2.41 p/Share
|
Oct 01
2020 |
SANW
|
Donald M. Panter Jr.
Executive VP, Americas |
BUY
Grant, award, or other acquisition
|
Direct | 15,684 Added 28.94% |
-
|
Oct 01
2020 |
SANW
|
Mark Wong |
BUY
Exercise of conversion of derivative security
|
Direct | 3,125 Added 1.17% |
-
|
Oct 01
2020 |
SANW
|
Mark Wong |
BUY
Grant, award, or other acquisition
|
Direct | 54,896 Added 17.37% |
-
|
Oct 01
2020 |
SANW
|
Mark Wong |
SELL
Payment of exercise price or tax liability
|
Direct | 3,472 Reduced 1.31% |
$8,368
$2.41 p/Share
|
Oct 01
2020 |
SANW
|
Matthew K Szot
EVP Finance & Admin and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,039 Added 0.75% |
-
|
Oct 01
2020 |
SANW
|
Matthew K Szot
EVP Finance & Admin and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 15,919 Added 10.5% |
-
|
Oct 01
2020 |
SANW
|
Matthew K Szot
EVP Finance & Admin and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,397 Reduced 1.02% |
$3,367
$2.41 p/Share
|
Oct 01
2020 |
KINS
|
Richard Jason Swartz
Chief Acctg Officer, Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 4,245 Added 37.22% |
-
|
Oct 01
2020 |
XTNT
|
Matthew Rizzo
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 58,754,394 Added 45.46% |
$62,867,205
$1.07 p/Share
|
Oct 01
2020 |
XTNT
|
Michael Eggenberg
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 58,754,394 Added 45.46% |
$62,867,205
$1.07 p/Share
|
Oct 01
2020 |
AAOI
|
Chih Hsiang (Thompson) Lin
President and CEO |
SELL
Open market or private sale
|
Direct | 7,788 Reduced 0.97% |
$87,381
$11.22 p/Share
|
Oct 01
2020 |
BTN
|
Fundamental Global Investors, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 700 Added 0.07% |
$1,120
$1.6 p/Share
|
Oct 01
2020 |
PCSA
|
Patrick Lin
Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct | 31,250 Added 7.25% |
$65,625
$2.1 p/Share
|
Oct 01
2020 |
PCSA
|
James H Stanker
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 6,000 Added 11.27% |
$12,600
$2.1 p/Share
|
Oct 01
2020 |
FREQ
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct | 15,716 Reduced 4.24% |
$303,162
$19.29 p/Share
|
Oct 01
2020 |
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 5.56% |
$150,720
$18.84 p/Share
|
Oct 01
2020 |
CULP
|
Fred A Jackson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 3.06% |
-
|
Oct 01
2020 |
CULP
|
Kenneth R Larson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 4.83% |
-
|
Oct 01
2020 |
CULP
|
Kenneth W Mcallister
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,113 Added 2.77% |
-
|
Oct 01
2020 |
CULP
|
Perry E Davis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 12.65% |
-
|
Oct 01
2020 |
CULP
|
Sharon A Decker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 11.62% |
-
|
Oct 01
2020 |
NTIP
|
Steven D. Heinemann
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 200 Reduced 0.01% |
$570
$2.85 p/Share
|
Oct 01
2020 |
LFVN
|
Steven R Fife
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,674 Reduced 1.08% |
$19,837
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Steven R Fife
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,770 Added 1.76% |
-
|
Oct 01
2020 |
LFVN
|
Kevin Mc Murray
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 672 Reduced 1.33% |
$7,963
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Kevin Mc Murray
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 981 Added 1.91% |
-
|
Oct 01
2020 |
LFVN
|
Justin Rose
Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 864 Reduced 0.56% |
$10,238
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Justin Rose
Chief Sales Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,178 Added 0.76% |
-
|
Oct 01
2020 |
LFVN
|
Charles J. Wach
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 752 Reduced 2.05% |
$8,911
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Charles J. Wach
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 981 Added 2.6% |
-
|
Oct 01
2020 |
HARP
|
Holger Wesche
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.96% |
$166,100
$16.61 p/Share
|
Oct 01
2020 |
HARP
|
Holger Wesche
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 13.76% |
$6,000
$0.6 p/Share
|
Oct 01
2020 |
LKCRU
|
Alan Mundt Scott
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 20,000 Added 25.0% |
$30,200
$1.51 p/Share
|
Oct 01
2020 |
LKCRU
|
Rick Alan Kasperson
Director |
BUY
Open market or private purchase
|
Indirect | 15,000 Added 11.54% |
$22,500
$1.5 p/Share
|
Oct 01
2020 |
NAII
|
Michael E Fortin
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,479 Reduced 4.34% |
$18,345
$7.4 p/Share
|
Oct 01
2020 |
NAII
|
Kenneth Wolf
President, COO, & Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 5,265 Reduced 3.77% |
$38,961
$7.4 p/Share
|
Oct 01
2020 |
PCF
|
Phillip Goldstein
Director |
SELL
Open market or private sale
|
Direct | 8,301 Reduced 8.01% |
$69,147
$8.33 p/Share
|
Oct 01
2020 |
SRT
|
Julie Schoenfeld
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,302 Added 12.35% |
-
|
Oct 01
2020 |
MLVF
|
James W Barrett
Director |
BUY
Open market or private purchase
|
Direct | 221 Added 1.76% |
$2,648
$11.98 p/Share
|
Oct 01
2020 |
MLVF
|
Julia D Corelli
Director |
BUY
Open market or private purchase
|
Direct | 201 Added 2.95% |
$2,408
$11.98 p/Share
|
Oct 01
2020 |